Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: An in vivo microdialysis study

Neurochemical Research

Volumn 35, Issue 4, 2010, Pages 559-563

  Ogaya, Tadahiro ^a   Song, Ziyu ^a   Ishii, Kana ^a   Fukushima, Takeshi ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Brain microdialysis; Column switching high performance liquid chromatography; D amino acid oxidase; D kynurenine; Kynurenic acid

Indexed keywords

3 METHYLPYRAZOLE 5 CARBOXYLIC ACID; AMINO ACID OXIDASE; BUNGAROTOXIN RECEPTOR; ENZYME INHIBITOR; KYNURENIC ACID; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; EXTRACELLULAR FLUID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; METABOLISM; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KYNURENIC ACID; KYNURENINE; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE;

RATTUS;

EID: 77953316471     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0099-1     Document Type: Article

References (41)

1. Borchers R, Berg CP, Whitman NE (1942) Tryptophane metabolism. X. The effect of feeding l(-)-, dl-, and d(+)-tryptophane, d(-)-and dl-β-3-indolelactic acid, β-3-indolepyruvic acid, and l(-)-kynurenine upon the storage of liver glycogen and the urinary output of kynurenic acid, kynurenine, and total acetone bodies. J Biol Chem 145:657-666
2. Leklem JE (1971) Quantitative aspects of tryptophan metabolism in humans and other species: a review. Amer J Clin Nutr 24:659-672
3. Mason M, Berg CP (1952) The metabolism of D-and L-tryptophan and D-and L-kynurenine by liver and kidney preparations. J Biol Chem 195:515-524
4. Langner RR, Berg CP (1955) Metabolism of D-tryptophan in the normal human subject. J Biol Chem 214:699-707
5. Higuchi K, Hayaishi O (1967) Enzymic formation of D-kynurenine from D-tryptophan. Arch Biochem Biophys 120:397-403
6. Loh HH, Berg CP (1971) Production of D-kynurenine and other metabolites from D-tryptophan by the intact rabbit and by rabbit tissue. J Nutr 101:465-475
7. Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375:87-100
8. Nemeth H, Toldi J, Vecsei L (2005) Role of kynurenines in the central and peripheral nervous systems. Curr Neurovascul Res 2:249-260
9. Ruddick JP, Evans AK, Nutt DJ et al (2006) Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 8:1-27
10. Hashimoto K, Koike K, Shimizu E et al (2005) α7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem Cent Nerv Syst Ag 5:171-184
11. Swartz KJ, During MJ, Freese A et al (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 10:2965-2973
12. Hilmas C, Pereira EFR, Alkondon M et al (2001) The brain metabolite kynurenic acid inhibits a7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463-7473
13. Schwarcz R, Rassoulpour A, Wu HQ et al (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiatr 50:521-530
14. Erhardt S, Blennow K, Nordin C et al (2001) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313:96-98
15. Nilsson LK, Linderholm KR, Engberg G et al (2005) Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res 80:315-322
16. Erhardt S, Schwieler L, Nilsson L et al (2007) The kynurenic acid hypothesis of schizophrenia. Physiol Behav 92:203-209
17. Okuno E, Schmidt W, Parks DA et al (1991) Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J Neurochem 57:533-540
18. Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50:457-465
19. Rossi F, Han Q, Li J et al (2004) Crystal structure of human kynurenine aminotransferase I. J Biol Chem 279:50214-50220 (Pubitemid 39577835)
20. Han Q, Robinson H, Li J (2008) Crystal structure of human kynurenine aminotransferase II. J Biol Chem 283:3567-3573
21. Rossi F, Garavaglia S, Montalbano V et al (2007) Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. J Biol Chem 283:3559-3566
22. Amori L, Guidetti P, Pellicciari R et al (2009) On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. J Neurochem 109:316-325
23. Guidetti P, Amori L, Sapko MT et al (2007) Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102:103-111
24. Fukushima T, Sone Y, Mitsuhashi S et al (2009) Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers. Chirality 21:468-472
25. Pilone MS (2000) D-Amino acid oxidase: new findings. Cell Mol Life Sci 57:1732-1747
26. Corvin A, Donohoe G, McGhee K et al (2007) D-Amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci Lett 426:97-100
27. Ono K, Shishido Y, Park HK et al (2009) Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain. J Neural Transm 116:1335-1347
28. Williams M (2009) Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. Biochem Pharmacol 78:1360-1365
29. Adage T, Trillat AC, Quattropani A et al (2008) In vitro and in vivo pharmacological profile of AS057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur Neuropsychopharmacol 18:200-214
30. Fukushima T, Kawai J, Imai K et al (2004) Simultaneous determination of D-and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed Chromatogr 18:813-819
31. Tomiya M, Fukushima T, Ogaya T et al (2009) Determination of kynurenic acid levels in rat brain microdialysis samples and changes in kynurenic acid levels induced by N-acetylaspartic acid. Biomed Chromatogr. doi: 10.1002/bmc.1336
32. Mitsuhashi S, Fukushima T, Kawai J et al (2006) Improved method for the determination of kynurenic acid in rat plasma by column-switching HPLC with post-column fluorescence detection. Anal Chim Acta 562:36-43
33. Fukushima T, Mitsuhashi S, Tomiya M et al (2007) Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. Clin Chim Acta 377:174-178
34. Fukushima T, Mitsuhashi S, Tomiya M et al (2007) Determination of rat brain kynurenic acid by column-switching HPLC with fluorescence detection. Biomed Chromatogr 21:514-519
35. Miller JM, MacGarvey U, Beal MF (1992) The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations. Neurosci Lett 146:115-118
36. Wu HQ, Pereira EFR, Bruno JP et al (2009) The astrocytederived a7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci. doi: 10.1007/s12031-009-9235-2
37. Mitsuhashi S, Fukushima T, Arai K et al (2007) Development of a column-switching high-performance liquid chromatography for kynurenine enantiomers and its application to a pharmacokinetic study in rat plasma. Anal Chim Acta 587:60-66
38. Tashiro M, Tsukada K, Kobayashi S et al (1961) A new pathway of D-tryptophan metabolism: enzymic formation of kynurenic acid via D-kynurenine. Biochem Biophys Res Commun 6:155-160
39. Schell MJ, Molliver ME, Snyder SH (1995) D-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92:3948-3952
40. Verrall L, Walker M, Rawlings N et al (2007) D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci 26:1657-1669
41. Madeira C, Freitas ME, Vargas-Lopes C et al (2008) Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res 101:76-83